Information Library
Results for: White Papers - Endocrinology
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Clinical Endpoint Committees - Summary
March 6, 2011
What are regulatory boards looking for in clinical endpoint committees? Read our executive summary on the current best practice across the industry. -
Clinical Endpoint Committees
February 22, 2011
As regulatory boards are expecting more from clinical endpoint committees, what guidance can you follow? This white paper sets forth current best practice for CECs. -
EMA’s Guidance on New Antidiabetic Drug Development
May 12, 2010
Assessing the EMA’s Guidance on New Antidiabetic Drug Development In January 2010, the European Medicines Agency (EMA) issued a draft guideline on antidiabetic drug development -
Data-Driven Patient Recruitment
March 23, 2010
Under pressure to deliver more evidence faster, drug developers are constantly searching for more patients for clinical trials. -
New FDA Guidance on Antidiabetic Therapies
December 11, 2009
Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.
Page 1 of 1 (5 results)
